Jamp Perindopril Erbumine 8 mg (Perindopril Erbumine TABLET) 8 MG

Perindopril Erbumine 8 MG tablets are an ACE inhibitor used to manage high blood pressure and heart conditions. This medication helps improve blood flow and reduce strain on the heart.

Strength

8 MG

Manufacturer / TM Owner

JAMP PHARMA CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Perindopril Erbumine 8 MG tablets are commonly used to treat high blood pressure, also known as hypertension. This medication works by relaxing blood vessels, making it easier for the heart to pump blood. It may also be prescribed for heart failure or to improve survival after a heart attack. Always consult a healthcare provider to determine if this medication is suitable for your condition.

Side Effects

Common effects of Perindopril Erbumine 8 MG tablets may include dizziness, headache, and fatigue. Some users might experience a persistent dry cough. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

Handle Perindopril Erbumine 8 MG tablets with care, especially if you have a history of kidney disease, liver problems, or are pregnant. Always follow the advice of a healthcare professional regarding the use of this medication. Keep out of reach of children and store in a cool, dry place.

Avoid Interactions

Perindopril Erbumine 8 MG tablets may interact with certain medications, including diuretics, NSAIDs, and potassium supplements. Alcohol consumption should be limited, as it can enhance the blood pressure-lowering effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Perindopril Erbumine is primarily used to treat high blood pressure and heart conditions, such as heart failure.

Perindopril Erbumine 8 MG tablets are typically taken orally, usually once a day. Follow the instructions provided by your healthcare provider.

Common side effects may include dizziness, headache, fatigue, and a persistent dry cough.

It is advisable to limit alcohol consumption while taking Perindopril Erbumine, as it can enhance the blood pressure-lowering effects.

Perindopril Erbumine is not recommended during pregnancy. Consult your healthcare provider for alternative options.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.